Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
AUBN
|
J Tutt Barrett |
BUY
Open market or private purchase
|
Direct | 40 Added 0.55% |
$1,546
$38.65 p/Share
|
Apr 01
2021 |
AUBN
|
Terry W Andrus
Director |
BUY
Open market or private purchase
|
Direct | 38 Added 1.02% |
$1,469
$38.65 p/Share
|
Apr 01
2021 |
LBSR
|
Pete O'Heeron
COB, Secretary, Treasurer |
BUY
Open market or private purchase
|
Direct | 14,726 Added 50.0% |
$15,021
$1.02 p/Share
|
Apr 01
2021 |
OSG
|
Saltchuk Resources, Inc. |
BUY
Open market or private purchase
|
Direct | 126,777 Added 0.87% |
$266,232
$2.1 p/Share
|
Apr 01
2021 |
FRME
|
Patrick A Sherman
Director |
BUY
Open market or private purchase
|
Direct | 10 Added 0.02% |
$471
$47.07 p/Share
|
Apr 01
2021 |
CHRW
|
Brian Short
Director |
BUY
Open market or private purchase
|
Direct | 53 Added 0.24% |
$5,186
$97.84 p/Share
|
Apr 01
2021 |
KFS
|
John Taylor Maloney Fitzgerald
President and CEO |
BUY
Open market or private purchase
|
Direct | 444 Added 0.02% |
$2,082
$4.69 p/Share
|
Apr 01
2021 |
CRTD
|
Jeremy Frommer
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.62% |
$8,900
$4.45 p/Share
|
Apr 01
2021 |
CARE
|
Litz H Van Dyke
CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct | 143 Added 0.78% |
$1,995
$13.95 p/Share
|
Apr 01
2021 |
CARE
|
Phyllis Q. Karavatakis
Director |
BUY
Open market or private purchase
|
Direct | 36 Added 0.2% |
$502
$13.95 p/Share
|
Apr 01
2021 |
CARE
|
Gregory W Feldmann
Director |
BUY
Open market or private purchase
|
Direct | 25 Added 0.33% |
$349
$13.95 p/Share
|
Apr 01
2021 |
CARE
|
Michael R Bird
Director |
BUY
Open market or private purchase
|
Direct | 35 Added 0.54% |
$488
$13.95 p/Share
|
Apr 01
2021 |
CARE
|
Arthur Loran Adams
EVP, DIRECTOR OF REG RISK MNGT |
BUY
Open market or private purchase
|
Direct | 21 Added 0.7% |
$293
$13.95 p/Share
|
Apr 01
2021 |
RGCO
|
Lawrence T. Oliver
VP and Secretary |
BUY
Open market or private purchase
|
Direct | 8 Added 0.25% |
$179
$22.41 p/Share
|
Apr 01
2021 |
RGCO
|
Randall P. Burton Ii |
BUY
Open market or private purchase
|
Direct | 4 Added 0.1% |
$90
$22.41 p/Share
|
Apr 01
2021 |
RGCO
|
Nancy H Agee
Director |
BUY
Open market or private purchase
|
Indirect | 66 Added 0.17% |
$1,479
$22.41 p/Share
|
Apr 01
2021 |
KFS
|
Paul R. Hogan
Secretary and General Counsel |
BUY
Open market or private purchase
|
Direct | 213 Added 5.09% |
$999
$4.69 p/Share
|
Apr 01
2021 |
AUBN
|
David E Housel |
BUY
Open market or private purchase
|
Direct | 28 Added 0.51% |
$1,082
$38.65 p/Share
|
Apr 01
2021 |
AUBN
|
Shannon O'Donnell
Senior Vice President |
BUY
Open market or private purchase
|
Direct | 14 Added 1.32% |
$541
$38.65 p/Share
|
Apr 01
2021 |
AUBN
|
William F Ham Jr |
BUY
Open market or private purchase
|
Direct | 30 Added 0.7% |
$1,160
$38.65 p/Share
|
Apr 01
2021 |
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.02% |
$14,000
$14.0 p/Share
|
Apr 01
2021 |
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 0.02% |
$14,000
$14.0 p/Share
|
Apr 01
2021 |
PFHO
|
Tom Kubota
CEO & President |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.03% |
$2,280
$1.14 p/Share
|
Apr 01
2021 |
KFS
|
Kent A Hansen
CFO & EVP |
BUY
Open market or private purchase
|
Direct | 319 Added 0.56% |
$1,496
$4.69 p/Share
|
Apr 01
2021 |
LOV
|
Osmium Partners, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 32,000 Added 1.16% |
$234,240
$7.32 p/Share
|
Apr 01
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.25% |
$4,800
$1600.0 p/Share
|
Apr 01
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 18 Added 0.04% |
$28,800
$1600.0 p/Share
|
Apr 01
2021 |
CTIC
|
Bvf Partners L P
Director |
BUY
Open market or private purchase
|
Direct | 2,000,000 Added 80.36% |
$5,000,000
$2.5 p/Share
|
Apr 01
2021 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.18% |
$1,741
$2.58 p/Share
|
Apr 01
2021 |
AGR
|
Alan D Solomont |
BUY
Open market or private purchase
|
Direct | 101 Added 1.37% |
$5,045
$49.95 p/Share
|
Apr 01
2021 |
FOLD
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct | 1,500 Added 3.26% |
$15,000
$10.0 p/Share
|
Apr 01
2021 |
HPK
|
Jack Hightower
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 164,250 Added 50.0% |
$1,072,553
$6.53 p/Share
|
Apr 01
2021 |
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 1,294 Added 0.06% |
$19,216
$14.85 p/Share
|
Apr 01
2021 |
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 1,294 Added 0.06% |
$19,216
$14.85 p/Share
|
Apr 01
2021 |
CTOS
|
James Carlsen
CIO |
BUY
Open market or private purchase
|
Direct | 20,000 Added 50.0% |
$100,000
$5.0 p/Share
|
Apr 01
2021 |
CTOS
|
Georgia R Nelson
Director |
BUY
Open market or private purchase
|
Direct | 25,000 Added 50.0% |
$125,000
$5.0 p/Share
|
Apr 01
2021 |
CTOS
|
Brad Meader
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 25,000 Added 50.0% |
$125,000
$5.0 p/Share
|
Apr 01
2021 |
CTOS
|
Adam G. Haubenreich
VP and General Counsel |
BUY
Open market or private purchase
|
Direct | 45,000 Added 50.0% |
$225,000
$5.0 p/Share
|
Apr 01
2021 |
CTOS
|
Mark Ein
Director |
BUY
Open market or private purchase
|
Direct | 1,000,000 Added 50.0% |
$5,000,000
$5.0 p/Share
|
Apr 01
2021 |
CTOS
|
Marshall Heinberg
Director |
BUY
Open market or private purchase
|
Direct | 100,000 Added 50.0% |
$500,000
$5.0 p/Share
|
Apr 01
2021 |
CTOS
|
Marshall Heinberg
Director |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 50.0% |
$250,000
$5.0 p/Share
|
Apr 01
2021 |
CTOS
|
Paul Bader
Director |
BUY
Open market or private purchase
|
Direct | 25,000 Added 50.0% |
$125,000
$5.0 p/Share
|
Apr 01
2021 |
CTOS
|
Ryan Mc Monagle
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 130,000 Added 50.0% |
$650,000
$5.0 p/Share
|
Apr 01
2021 |
CVLY
|
John Rodney Messick
Director |
BUY
Open market or private purchase
|
Direct | 200 Added 4.63% |
$3,708
$18.54 p/Share
|
Apr 01
2021 |
ISBA
|
Julie Huber
VP & Chief Technology Officer |
BUY
Open market or private purchase
|
Direct | 4 Added 3.25% |
$83
$20.66 p/Share
|
Apr 01
2021 |
ISBA
|
Jerome E Schwind
President & CEO |
BUY
Open market or private purchase
|
Direct | 19 Added 0.13% |
$393
$20.66 p/Share
|
Apr 01
2021 |
ISBA
|
Jennifer L Gill
VP & Controller |
BUY
Open market or private purchase
|
Direct | 2 Added 0.19% |
$41
$20.66 p/Share
|
Apr 01
2021 |
HEOL
|
Gerald R Forsythe
Director |
BUY
Open market or private purchase
|
Direct | 1 Added 0.25% |
$5,800
$5800.0 p/Share
|
Apr 01
2021 |
WINT
|
Craig Fraser
President and CEO |
BUY
Open market or private purchase
|
Direct | 500 Added 1.83% |
$1,230
$2.46 p/Share
|
Apr 01
2021 |
IGXT
|
Bernard Boudreau
Director |
BUY
Open market or private purchase
|
Direct | 12,500 Added 7.79% |
$5,875
$0.47 p/Share
|
Apr 01
2021 |